How many insider declarations has Slingsby Brian Taylor filed?

Slingsby Brian Taylor has filed 4 public insider declarations with SEC (Form 4).

What is Slingsby Brian Taylor's role?

Slingsby Brian Taylor's reported role is not specified by the regulator across the filings.

Which companies does Slingsby Brian Taylor report trades for?

Slingsby Brian Taylor reports trades for Mineralys Therapeutics, Inc..

What is Slingsby Brian Taylor's declared buy vs sell volume?

Across the available history, declared buys total 3.2M€ and disposals 44.2M€.

← Executives ★ Sign in to follow

SB

Slingsby Brian Taylor

·SEC (Form 4)

Mineralys Therapeutics, Inc.

累计流向

0

申报总数

0

公司

€322万

▲ 买入（1 笔）

€4418万

▼ 卖出（2 笔）

内部人交易记录

其他

已披露买入

1

已披露卖出

2

T+90 胜率

0%

T+90 平均收益

-12.4%

基于 2 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。

信号历史

Discover the detailed record of transactions filed by Slingsby Brian Taylor. Director active across 1 company, notably Mineralys Therapeutics, Inc.. Aggregated, 4 disclosures have been recorded. Split: 1 buy · 2 sells. Total volume traded: €47.4m. History available since 24 July 2024. The latest transaction was filed on 20 November 2025 (Cession). Regulator: SEC (Form 4). The full history is free.

Companies and markets linked to Slingsby Brian Taylor

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Mineralys Therapeutics, Inc. (US)

申报4 总计

▼

Slingsby Brian Taylor

Director高管2025年11月20日Mineralys Therapeutics, Inc.

US$4335万0SEC ↗

1,000,000 股@ US$43.35Common StockSEC:0001933414-25-000156:0

▲

Slingsby Brian Taylor

Director高管2025年3月13日Mineralys Therapeutics, Inc.

US$350万32SEC ↗

259,259 股@ US$13.5032.7% 占其流量Common StockSEC:0001933414-25-000052:0

标准退出：2025年6月11日 (T+90)

▼

Slingsby Brian Taylor

Director高管2024年7月24日Mineralys Therapeutics, Inc.

US$718万33SEC ↗

550,000 股@ US$13.0567.3% 占其流量Common StockSEC:0001628280-24-033205:0

●

Slingsby Brian Taylor

Director高管2023年2月14日Mineralys Therapeutics, Inc.

11SEC ↗

4,314,093 股Common StockSEC:0001628280-23-003922:0

4 条申报中的 4 条

InsidersTradesSigma

← Executives ★ Sign in to follow

SB

Slingsby Brian Taylor

·SEC (Form 4)

Mineralys Therapeutics, Inc.

累计流向

0

申报总数

0

公司

€322万

▲ 买入（1 笔）

€4418万

▼ 卖出（2 笔）

内部人交易记录

其他

已披露买入

1

已披露卖出

2

T+90 胜率

0%

T+90 平均收益

-12.4%

基于 2 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。

信号历史

Discover the detailed record of transactions filed by Slingsby Brian Taylor. Director active across 1 company, notably Mineralys Therapeutics, Inc.. Aggregated, 4 disclosures have been recorded. Split: 1 buy · 2 sells. Total volume traded: €47.4m. History available since 24 July 2024. The latest transaction was filed on 20 November 2025 (Cession). Regulator: SEC (Form 4). The full history is free.